Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 357 Records) |
Query Trace: Disease Progression and EGFR[original query] |
---|
Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib. BMC cancer 2023 9 23 (1): 834. Kensuke Kanaoka, Hiromitsu Sumikawa, Shunsuke Oyamada, Akihiro Tamiya, Yuji Inagaki, Yoshihiko Taniguchi, Keiko Nakao, Yoshinobu Matsuda, Kyoichi Okish |
The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study. Cancer medicine 2023 9 . Shuyang Zhang, Lu Yang, Yaning Yang, Guangjian Yang, Haiyan Xu, Xueliang Niu, Yan Wa |
Nivolumab as maintenance therapy following platinum-based chemotherapy in EGFR-mutant lung cancer patients after tyrosine kinase inhibitor failure: A single-arm, open-label, phase 2 trial. Thoracic cancer 2023 9 . Jiwon Kim, Chang-Min Choi, Wonjun Ji, Jae Cheol L |
First-generation EGFR-TKI plus bevacizumab and chemotherapy for advanced EGFR-mutated non-squamous non-small-cell lung cancer: a retrospective study. Annals of medicine 2023 8 55 (2): 2243967. Yahua Wu, Bin Du, Chengliu Lv, Xiaohui Ji, Yanqin Lan, Na Yao, Yingjiao Zhu, Jinhuo L |
Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial. Journal of cancer research and clinical oncology 2023 7 . Aidong Qu, Shiying Zhang, Hongxia Zou, Sixiu Li, Dandan Chen, Yaowen Zhang, Songsong Li, Huijun Zhang, Ji Yang, Yunkai Yang, Yubao Huang, Xiuling Li, Yuntao Zha |
Selpercatinib monotherapy in a Chinese patient with RET fusion/EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report. Anti-cancer drugs 2023 6 . Lin Wu, Ying Cheng, Dingzhi Huang, Yuping Sun, Chengzhi Zhou, Jianying Zhou, Ye Guo, Jingxin Shao, Wanli Zhang, Shun |
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study. The Lancet. Respiratory medicine 2023 5 . Shun Lu, Jianying Zhou, Hong Jian, Lin Wu, Ying Cheng, Yun Fan, Jian Fang, Gongyan Chen, Zhihong Zhang, Dongqing Lv, Liyan Jiang, Rong Wu, Xiangming Jin, Xiaodong Zhang, Junhong Zhang, Conghua Xie, Gengyun Sun, Dongning Huang, Jiuwei Cui, Renhua Guo, Zhigang Han, Zhendong Chen, Jin Liang, Wu Zhuang, Xingsheng Hu, Aimin Zang, Yi Zhang, Shundong Cang, Yuanbo Lan, Xi Chen, Laiyu Liu, Xingya Li, Jun Chen, Rui Ma, Yanzhen Guo, Ping Sun, Panwen Tian, Yueyin Pan, Zhe Liu, Peiguo Cao, Lieming Ding, Yang Wang, Xiaobin Yuan, Pengxiang |
Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant ( L833V / H835L ) lung adenocarcinoma patient : a case report. Anti-cancer drugs 2023 5 . Zhilin Luo, Chengwen Luo, Runquan Zhou, Yajie Xiao, Tianhu Wa |
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
Chemotherapy outcomes in EGFR-TKI resistant patients with common and uncommon EGFR mutation: An exploratory retrospective cohort study. Thoracic cancer 2023 5 . Chien-Yu Lin, Chia-Hao Hu, Chia-Fu Hsu, Jeng-Shiuan Tsai, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung L |
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 12 JCO2302219. Pasi A Jänne, David Planchard, Kunihiko Kobayashi, Ying Cheng, Chee Khoon Lee, Natalia Valdiviezo, Konstantin Laktionov, Tsung-Ying Yang, Yan Yu, Terufumi Kato, Liyan Jiang, Busyamas Chewaskulyong, Sarayut Lucien Geater, Jean-Marc Maurel, Carlos Rojas, Toshiaki Takahashi, Libor Havel, Frances A Shepherd, Kentaro Tanaka, Dana Ghiorghiu, Neha P Amin, Elena Armenteros-Monterroso, Xiangning Huang, Ammar Ahmed Chaudhry, James Chih-Hsin Ya |
Influence of Smoking Habits on the Efficacy of EGFR-TKI Therapy in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis. Clinical Medicine Insights. Oncology 2023 12 17 11795549231215968. Zexun Mo, Meifeng Ye, Hua He, Xiaomei Huang, Weihong Guo, Ziwen Zhao, Yujun Li, Shuquan W |
Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI. Cancer biomarkers : section A of Disease markers 2023 12 . David Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde, Edgar Varela Santoyo, Luis Lara-Mejía, Daniela Cárdenas-Fernández, Mario Orozco, Graciela Cruz-Rico, Oscar Arrie |
Aumolertinib: effective treatment for asymptomatic pulmonary giant cell carcinoma with EGFR L858R mutation - a case report. Frontiers in oncology 2023 12 13 1279045. Wenxing Yang, Ze Yang, Kaiqiang Wang, Peiquan Zhu, Jiangtao |
Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide. European journal of clinical investigation 2023 12 e14147. Shosha E I Dekker, Jörgen Bierau, Martin Giera, Niek Blomberg, Joost P H Drenth, Oleg A Mayboroda, Johan W de Fijter, Darius Soonawala, |
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC. The New England journal of medicine 2023 11 . David Planchard, Pasi A Jänne, Ying Cheng, James C-H Yang, Noriko Yanagitani, Sang-We Kim, Shunichi Sugawara, Yan Yu, Yun Fan, Sarayut L Geater, Konstantin Laktionov, Chee K Lee, Natalia Valdiviezo, Samreen Ahmed, Jean-Marc Maurel, Igor Andrasina, Jonathan Goldman, Dana Ghiorghiu, Yuri Rukazenkov, Alex Todd, Kunihiko Kobayashi, |
IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in immunology 2023 11 14 1282734. Qisheng Luo, Junhong Zhuang, Dandan Zheng, Changfeng Miao, Hongcheng Luo, Jun Peng, Chuanhua Zheng, Chengjian Qin, Chuanliu Lan, Meiqin Chen, Ying Xia, Deyou Huang, Zigui Ch |
Anti-epidermal growth factor receptor treatment for patients with NeoRAS wild-type metastatic colorectal cancer: a case report of two cases. Therapeutic advances in medical oncology 2023 11 15 17588359231216090. Kazuaki Harada, Satoshi Yuki, Yasuyuki Kawamoto, Takeaki Nakamura, Shiho Kaneko, Koichi Ishida, Naoya Sakamoto, Yoshito Komat |
Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 10 . Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, F Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Julia Dietz, Emily Duffield, Scott Gettinger, Katerina Politi, Sarah B Goldbe |
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C. The New England journal of medicine 2023 10 . Marwan G Fakih, Lisa Salvatore, Taito Esaki, Dominik P Modest, David P Lopez-Bravo, Julien Taieb, Michalis V Karamouzis, Erika Ruiz-Garcia, Tae-Won Kim, Yasutoshi Kuboki, Fausto Meriggi, David Cunningham, Kun-Huei Yeh, Emily Chan, Joseph Chao, Yaneth Saportas, Qui Tran, Chiara Cremolini, Filippo Pietranton |
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial. EClinicalMedicine 2023 10 64 102238. Si-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, Yingying Du, Jiu-Wei Cui, Qian Chu, Bing-Fei Xu, Ming-Ying Zheng, Jia-Yi Deng, Chang Lu, Xue-Wu Wei, Yang-Si Li, Mei-Mei Zheng, Ming-Yi Yang, Jie Huang, Anna Li, Xiao-Yan Bai, Yue-Li Sun, Chong-Rui Xu, Bin-Chao Wang, Hua-Jun Chen, Jin-Ji Yang, Hong-Hong Yan, Wen-Zhao Zhong, Qing Zhou, Yi-Long |
GlioPredictor: a deep learning model for identification of high-risk adult IDH-mutant glioma towards adjuvant treatment planning. Scientific reports 2024 1 14 (1): 2126. Shuhua Zheng, Nikhil Rammohan, Timothy Sita, P Troy Teo, Yilin Wu, Maciej Lesniak, Sean Sachdev, Tarita O Thom |
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: Final Results of CheckMate 722. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 1 JCO2301017. Tony Mok, Kazuhiko Nakagawa, Keunchil Park, Yuichiro Ohe, Nicolas Girard, Hye Ryun Kim, Yi-Long Wu, Justin Gainor, Se-Hoon Lee, Chao-Hua Chiu, Sang-We Kim, Cheng-Ta Yang, Chien Liang Wu, Lin Wu, Meng-Chih Lin, Jens Samol, Kazuya Ichikado, Mengzhao Wang, Xiaoqing Zhang, Judi Sylvester, Sunney Li, Ann Forslund, James Chih-Hsin Ya |
EGFR-TKI rechallenge in patients with EGFR-mutated non-small-cell lung cancer who progressed after first-line osimertinib treatment: A multicenter retrospective observational study. Respiratory investigation 2024 1 62 (2): 262-268. Taisuke Araki, Shintaro Kanda, Miho Obara, Toshihiko Agatsuma, Yumiko Kakizaki, Mineyuki Hama, Hiroshi Yamamoto, Munetake Takada, Manabu Yamamoto, Akemi Matsuo, Daichi Kondo, Masamichi Komatsu, Kei Sonehara, Kazunari Tateishi, Masayuki Hanaoka, Tomonobu Koizu |
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma. Contemporary oncology (Poznan, Poland) 2024 1 27 (3): 211-216. Julia Pikul, Anna Rzepakowska, Marcin Machnicki, Tomasz Stok?o |
Efficacy of Adjuvant First-Generation TKIs versus Chemotherapy in Patients with Completely Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis. Cancer investigation 2024 1 1-12. Bin Shen, Dongping Wu, Jianjiang Liu, Yang Ya |
Combining genotype with height-adjusted kidney length predicts rapid progression of ADPKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2024 1 . Eugene W C Chen, Jiehan Chong, Manoj K Valluru, Miranda Durkie, Roslyn J Simms, Peter C Harris, Albert C M O |
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC). Translational lung cancer research 2024 1 12 (12): 2448-2459. Dae-Ho Choi, Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Se-Hoon L |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: